More articles from Pulmonary vascular disease

Clinical features and long-term survival in idiopathic pulmonary arterial hypertension with thyroid dysfunction: insights from a national multicentre prospective study
Yuling Qian, Ruilin Quan, Xiaoxi Chen, Gangcheng Zhang, Yuanhua Yang, Yucheng Chen, Zaixin Yu, Qing Gu, Changming Xiong, Huijun Han, Jianguo He

ERJ Open Research Nov 2023, 9 (6) 00495-2023; DOI: 10.1183/23120541.00495-2023
Management of systemic to pulmonary shunts and elevated pulmonary vascular resistance
Alexandra N. Linder, Jill Hsia, Sheila V. Krishnan, Emile A. Bacha, Sarah Crook, Erika B. Rosenzweig, Usha S. Krishnan

ERJ Open Research Nov 2023, 9 (6) 00271-2023; DOI: 10.1183/23120541.00271-2023
Impact of targeted pulmonary arterial hypertension therapies in severe pulmonary hypertension in chronic lung diseases
Romain Naud, Julien Bermudez, Noémie Resseguier, Ana Nieves, Bérengère Coltey, Nadine Dufeu, Clarisse Gautier, Youssef Trigui, Marc Laine, Benjamin Coiffard, Martine Reynaud-Gaubert

ERJ Open Research Jul 2023, 9 (4) 00027-2023; DOI: 10.1183/23120541.00027-2023
Gut microbiome alterations in pulmonary hypertension in highlanders and lowlanders
Wenxue Dong, Lifeng Ma, Qiumin Huang, Xu Yang, Zhendong Mei, Mengmeng Kong, Zhonghan Sun, Zhiying Zhang, Jing Li, Jiaojiao Zou, Dandan Chen, Yuxiang Dai, Daxin Zhou, Yan Zheng, Longli Kang

ERJ Open Research May 2023, 9 (3) 00617-2022; DOI: 10.1183/23120541.00617-2022
Residual risk identified in routine noninvasive follow-up assessments in pulmonary arterial hypertension
Jonna Ostermann, Julian Pott, Jan K. Hennigs, Kevin Roedl, Christoph Sinning, Lars Harbaum, Hans Klose

ERJ Open Research May 2023, 9 (3) 00072-2023; DOI: 10.1183/23120541.00072-2023
Prognostic role of different findings at echocardiography in acute pulmonary embolism: a critical review and meta-analysis
Ludovica Anna Cimini, Matteo Candeloro, Magdalena Pływaczewska, Giorgio Maraziti, Marcello Di Nisio, Piotr Pruszczyk, Giancarlo Agnelli, Cecilia Becattini

ERJ Open Research Mar 2023, 9 (2) 00641-2022; DOI: 10.1183/23120541.00641-2022
Hyperoxia improves exercise capacity in cardiopulmonary disease: a series of randomised controlled trials
Julian Müller, Mona Lichtblau, Stéphanie Saxer, Simon R. Schneider, Paula Appenzeller, Meret Bauer, Elisabeth D. Hasler, Esther I. Schwarz, Konrad E. Bloch, Silvia Ulrich

ERJ Open Research Mar 2023, 9 (2) 00563-2022; DOI: 10.1183/23120541.00563-2022
Pulmonary arterial compliance and exercise capacity after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension
Romain Sermet, Nicolas Piliero, Alicia Guillien, Simon Madoun, Stéphane Doutreleau, Muriel Salvat, Mathieu Finas, Frédéric Thony, Estelle Vautrin, Hélène Bouvaist, Bruno Degano

ERJ Open Research Mar 2023, 9 (2) 00590-2022; DOI: 10.1183/23120541.00590-2022
AV-101, a novel inhaled dry-powder formulation of imatinib, in healthy adult participants: a phase 1 single and multiple ascending dose study
Hunter Gillies, Ralph Niven, Benjamin T. Dake, Murali M. Chakinala, Jeremy P. Feldman, Nicholas S. Hill, Marius M. Hoeper, Marc Humbert, Vallerie V. McLaughlin, Martin Kankam

ERJ Open Research Mar 2023, 9 (2) 00433-2022; DOI: 10.1183/23120541.00433-2022
Clinical phenotyping of plasma thrombospondin-2 reveals relationship to right ventricular structure and function in pulmonary hypertension
Anna M. Dittrich, Julia Mienert, Julian Pott, Lena Engels, Christoph Sinning, Jan K. Hennigs, Hans Klose, Lars Harbaum

ERJ Open Research Mar 2023, 9 (2) 00528-2022; DOI: 10.1183/23120541.00528-2022

Main menu

User menu

Search

More articles from Pulmonary vascular disease

Pages

Contact us